C12N 2760/14123
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2760/14123 (Virus like particles [vlp]) appears on 13 US grants and 30 published applications in this corpus.
Search patents in C12N- Granted patents
- 13
- Published applications
- 30
- Assignees
- 12
- Inventors
- 41
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 3 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 5 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 3 |
| 2019 | 0 | 0 |
| 2020 | 1 | 4 |
| 2021 | 2 | 4 |
| 2022 | 2 | 1 |
| 2023 | 0 | 1 |
| 2024 | 2 | 2 |
| 2025 | 3 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- VLP-based monovalent ebola vaccines and methods of making and using same30 Sep 2025US 12,427,190 B2Children's Hospital Medical Center
- Recombinant biologically contained filovirus vaccine1 Jul 2025US 12,343,390 B2Wisconsin Alumni Research Foundation (WARF)
- VLP-based bivalent Ebola vaccines and methods of making and using same22 Apr 2025US 12,280,100 B2Children's Hospital Medical Center
- Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein19 Nov 2024US 12,144,857 B2Wisconsin Alumni Research Foundation (WARF)
- VLP-based bivalent ebola vaccines and methods of making and using same6 Feb 2024US 11,890,337 B2Children's Hospital Medical Center
- Engineered virus-like-particles for targeted capture of membrane proteins16 Jul 2026US 2026/0200991 A1
- Multivalent viral particles21 Nov 2024US 2024/0382580 A1Cornell University
- Vlp-based bivalent ebola vaccines and methods of making and using same25 Apr 2024US 2024/0131141 A1Children's Hospital Medical Center
- Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (ha) protein22 Jun 2023US 2023/0190913 A1Wisconsin Alumni Research Foundation (WARF)
- Compositions and methods useful for ebola virus infection10 Nov 2022US 2022/0356476 A1AIM ImmunoTech Inc.
Most cited
By later US patents
- Generation of virus-like particles and use as panfilovirus vaccine20US 7,682,618 B2The United States of America as represented by the Secretary of the Army · 2010
- Filovirus vectors and noninfectious filovirus-based particles17US 7,211,378 B2Wisconsin Alumni Research Foundation · 2007
- Filovirus vectors and noninfectious filovirus-based particles16US 8,900,595 B2Wisconsin Alumni Research Foundation · 2014
- Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein13US 11,389,523 B2Wisconsin Alumni Research Foundation (WARF) · 2022
- VLP-based bivalent Ebola vaccines and methods of making and using same2US 11,129,886 B2Children's Hospital Medical Center · 2021